MedPointe expands sales force with Innovex
Quintiles contract sales subsidiary Innovex will recruit and train 120 sales reps for MedPointe. The additional force increases MedPointe's total sales reps to 300 and expands the number of primary care doctors called on from 28,000 to 50,000. Training will focus on the antihistamine nasal spray Astelin and cold products Ryna/Tussi; recruitment should be completed by March. Medpointe, lead by former Warner-Lambert exec Anthony Wild, acquired Carter-Wallace's prescription business in October (1"The Pink Sheet" May 14, 2001, p. 13)...
You may also be interested in...
A successor to the anti-epileptic Felbatol is among the development projects for Carter-Wallace's healthcare unit following its acquisition by an investment firm run by former Warner-Lambert exec Anthony Wild.
Roche is hoping the investigational oral drug can help it expand its presence in breast cancer and break into the prostate cancer market – but the signals are decidedly mixed.
CDRH director Jeff Shuren says the US agency’s device center has been tallying up lessons learned from the COVID-19 pandemic.